PATENT CLAIM ANALYSIS

Application Number: 16028730
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "235200"]

Abstract:
The invention provides methods of treatment of a progressive bone disease, such as osteoporosis, Paget's Disease, multiple myeloma, or hyperparathyroidism, comprising administration of an effective amount of a non-agonist PPARG modulator to a patient afflicted with the disease.

Claim (Index 8):
The method of  claim 1 , wherein Y is C 1 -alkyl; and R 5  and R 6  are H, or wherein Y is C 2 -alkyl, and R 5  and R 6  are H.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 95.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15302862', '13490324', '13490342', '13811965', '14060563']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.746860838177867
- 35 USC 102 Novelty (BERT): 0.6169317475756405
- Combined Prediction Score: 0.7338679291176444
- Mean Citation Score: 348.215824
- Max Citation Score: 526.92584
- Similarity Product: 515.0007041554737

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test